Clinical applications of immunoscintigraphy for prostate cancer

Keyphrases

• Prostate Cancer 100%
• Clinical Application 100%
• Computed Tomography 100%
• Primary Therapy 100%
• Immunoscintigraphy 100%
• Cardiac Magnetic Resonance Imaging (cMRI) 66%
• Recurrent Disease 66%
• Bone Scan 66%
• Extraprostatic Disease 66%
• Imaging Techniques 33%
• Clinically Significant 33%
• Lymph Node 33%
• Tumor 33%
• Radiation Therapy 33%
• Radiologic 33%
• Residual Disease 33%
• Optimal Therapy 33%
• Prostate-specific Antigen 33%
• Endorectal 33%
• Nodal Metastasis 33%
• Radical Prostatectomy 33%
• Accurate Staging 33%
• Magnetic Resonance Imaging Scan 33%
• Extrapelvic 33%
• Biochemical Failure 33%
• Gleason 33%
• Metastatic Site 33%
• Bone Involvement 33%
• Periprostatic 33%
• Nuclear Scintigraphy 33%
• Size Criteria 33%
• Extraprostatic 33%
• Soft Tissue Involvement 33%
• Disease Extent 33%
• Lymph Node Tissue 33%
• Recurrence or Metastasis 33%

Medicine and Dentistry

• Prostate Cancer 100%
• Immunoscintigraphy 100%
• Diseases 100%
• Magnetic Resonance Imaging 60%
• Computer Assisted Tomography 60%
• Recurrent Disease 60%
• Lymph Node 40%
• Bone Scintigraphy 40%
• Prostatectomy 20%
• Metastatic Carcinoma 20%
• Scintigraphy 20%
• Clinical Stage 20%
• False Negative Result 20%
• Prostate Specific Antigen 20%
• Minimal Residual Disease 20%
• Biochemical Recurrence 20%
• Tumor 20%
• Nodal Metastasis 20%
• Radiation Therapy 20%